Porous Baseplate in Total Knee Replacement

December 3, 2025 updated by: Canadian Radiostereometric Analysis Network

A Prospective, Multicenter, RSA Study of the Porous Tibia Baseplate W/Jrny Lock

This is a multi-centre single cohort trial of patients undergoing cruciate-retaining total knee arthroplasty with the Advance Porous fixed bearing tibial baseplate and compatible femoral, patellar, and bearing components.

Study Overview

Status

Active, not recruiting

Conditions

Detailed Description

All patients will undergo post-operative model-based RSA to identify migration of the tibial baseplate with respect to the bone as well as migration of the patellar and femoral components with respect to the bone during the first 2 post-operative years. Patient health and functional outcomes will be recorded at pre- and post-operative intervals for all patients. Peri-operative adverse events and other clinical complications will be captured as encountered.

Study Type

Interventional

Enrollment (Actual)

31

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Manitoba
      • Winnipeg, Manitoba, Canada, R2K 3S8
        • Concordia Hospital
    • Ontario
      • London, Ontario, Canada, N6A 5W9
        • London Health Sciences Centre

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Symptomatic osteoarthritis of the knee indicating primary unilateral total knee arthroplasty
  • Sufficient ligamentous function to warrant retention of the posterior cruciate ligament
  • Aged 21 years or older
  • Patients willing and able to comply with follow-up requirements and self-evaluations
  • Ability to give informed consent

Exclusion Criteria:

  • Active or prior infection
  • Medical condition precluding major surgery
  • Known medical condition limiting patient life expectancy to < 2 years
  • Expected to receive contralateral TKA within 1 year
  • Inflammatory arthropathy
  • Prior patellectomy
  • PCL deficiency
  • Major (>25 degree) coronal plane deformity
  • Bilateral coronal plane deformity requiring simultaneous bilateral TKA
  • Bone defects requiring augments, cones and/or stemmed implants
  • Body Mass Index greater than 40

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: POROUS TIBIA BASEPLATE W/ JRNY LOCK
Fixed-bearing POROUS TIBIA BASEPLATE W/ JRNY LOCK and a Legion cruciate-retaining High-Flex or Deep-dish XLPE tibial insert.
Fixed-bearing POROUS TIBIA BASEPLATE W/ JRNY LOCK and a Legion cruciate-retaining High-Flex or Deep-dish XLPE tibial insert

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change between 6 months and 1-year post-operative - tibial baseplate stability
Time Frame: 6 Months and 1 Year
Maximum total point motion (MTPM) migration of the POROUS TIBIA BASEPLATE W/ JRNY LOCK between 6 months and 1 year post-operative (mm)
6 Months and 1 Year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change between 1- and 2-years post-operative - tibial baseplate stability
Time Frame: 1 Year and 2 Years
Maximum total point motion (MTPM) migration of the POROUS TIBIA BASEPLATE W/ JRNY LOCK between 1 year and 2 years post-operative (mm)
1 Year and 2 Years
Total MTPM migration of the baseplate at 1 year
Time Frame: 1 Year
Assessment of the stability of the tibial baseplate (mm)
1 Year
Establish the post-operative migration pattern of the patellar and femoral components
Time Frame: 6 Weeks and 6 Months
Assessment of the migration pattern (mm)
6 Weeks and 6 Months
What is the magnitude of baseplate displacement that results from patient weight-bearing (single leg stance) versus non-weight-bearing at 1-year post-operation?
Time Frame: 1 Year
Assessment of the baseplate displacement differences between standing and supine RSA (mm)
1 Year
European Quality of Life (EQ-5D-5L)
Time Frame: Preoperative, 6 Weeks, 6 Months, 1 Year and 2 Years
EQ5D consists of 5 subscales; Mobility, Self-care, Usual activities, Pain/Discomfort and Anxiety / depression. A health state score is obtained based on the responses from 1-5 in each subscale, from which a single index value is calculated representing patients' overall health state. EQ5D includes a so called EQ VAS score which is the patients' self-rated health on a 20 cm vertical, visual analogue scale with endpoints labelled "the best health you can imagine" and "the worst health you can imagine".
Preoperative, 6 Weeks, 6 Months, 1 Year and 2 Years
Patient-reported Outcome: Oxford Knee Score
Time Frame: Preoperative, 6 Weeks, 6 Months, 1 Year and 2 Years
The Oxford Knee Score (OKS) is a patient self-administered 12-item questionnaire with each question having a Likaert-like response option. Each item is scored from 0 to 4, and the items are summated, with lower total scores indicating poorer performance. The OKS measures pain and general activities of daily living.
Preoperative, 6 Weeks, 6 Months, 1 Year and 2 Years
Forgotten Joint Score (FJS)
Time Frame: Preoperative, 6 Weeks, 6 Months, 1 Year and 2 Years
The FJS total score range is 0-100, higher scores indicating the patient is able to forget the joint daily or lower degree of joint awareness.
Preoperative, 6 Weeks, 6 Months, 1 Year and 2 Years
Knee Injury and Osteoarthritis Outcomes Score (KOOS JR.)
Time Frame: Preoperative, 6 Weeks, 6 Months, 1 Year and 2 Years
The KOOS JR. was a participant completed questionnaire that consists of 7 questions from 3 subscales: stiffness (1 question), pain (4 questions), and function in daily living (2 questions). Standardized answer options are given (5 Likert boxes) and each question was assigned a score from none (0) to extreme (4).
Preoperative, 6 Weeks, 6 Months, 1 Year and 2 Years
University of California at Los Angeles (UCLA) Activity Level scale
Time Frame: Preoperative, 6 Weeks, 6 Months, 1 Year and 2 Years
Evaluate and compare the change in UCLA activity score compared to baseline in the study cohort. UCLA activity scores range from 1 to 10, and is a measure of activity with 10 being most active.
Preoperative, 6 Weeks, 6 Months, 1 Year and 2 Years
Pain VAS
Time Frame: Preoperative, 6 Weeks, 6 Months, 1 Year and 2 Years
Evaluate and compare the change from preoperative to 2 years between the study groups timepoints in patient reported satisfaction as measured using the visual analogue scale (VAS) from 0 (No pain) - 100 (Worst pain imaginable)
Preoperative, 6 Weeks, 6 Months, 1 Year and 2 Years
Satisfaction VAS
Time Frame: Preoperative, 6 Months, 1 Year and 2 Years
Evaluate and compare the change from preoperative to 2 years between the study groups timepoints in patient reported pain severity as measured using the visual analogue scale (VAS) from 0 (Unsatisfied) - 100 (Completely satisfied)
Preoperative, 6 Months, 1 Year and 2 Years
Patient complications
Time Frame: 6 Weeks, 6 Months, 1 Year and 2 Years
Evaluate the type and frequency of the complications/adverse events.
6 Weeks, 6 Months, 1 Year and 2 Years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Douglas Naudie, MD, London Health Sciences Centre

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 11, 2022

Primary Completion (Actual)

April 8, 2025

Study Completion (Estimated)

July 1, 2026

Study Registration Dates

First Submitted

January 3, 2022

First Submitted That Met QC Criteria

February 4, 2022

First Posted (Actual)

February 7, 2022

Study Record Updates

Last Update Posted (Estimated)

December 4, 2025

Last Update Submitted That Met QC Criteria

December 3, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • B2021:110

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Knee Osteoarthritis

Subscribe